Advanced search
Publication Cover
Leukemia & Lymphoma Volume 54, 2013 - Issue 5
Submit an article Journal homepage
578
Views
4
CrossRef citations to date
0
Altmetric
Review Article

Selection of rituximab dosage in chronic lymphocytic leukemia: where is the evidence?

Constantine S. TamHaematology Department, Peter MacCallum Cancer Centre, St Andrew's Place, East Melbourne 3002 Victoria, AustraliaCorrespondence[email protected]
&
Michael J. KeatingDepartment of Leukemia, Division of Cancer Medicine, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Pages 934-939 | Received 22 May 2012, Accepted 06 Sep 2012, Published online: 28 Sep 2012

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Nimish Shah, Constantine Tam, John F. Seymour & Simon Rule. (2015) How applicable is fludarabine, cyclophosphamide and rituximab to the elderly?. Leukemia & Lymphoma 56:6, pages 1599-1610.
Read now

Articles from other publishers (3)

James D’Rozario & Samuel K. Bennett. (2019) Update on the role of venetoclax and rituximab in the treatment of relapsed or refractory CLL. Therapeutic Advances in Hematology 10, pages 204062071984469.
Crossref
Tanya Siddiqi & Steven T. Rosen. 2017. Management of Lymphomas: A Case-Based Approach. Management of Lymphomas: A Case-Based Approach 47 73 .
Noriki Okada, Yukihiro Sanada, Yuta Hirata, Naoya Yamada, Taiichi Wakiya, Yoshiyuki Ihara, Taizen Urahashi, Atsushi Miki, Yuji Kaneda, Hideki Sasanuma, Takehito Fujiwara, Yasunaru Sakuma, Atsushi Shimizu, Masanobu Hyodo, Yoshikazu Yasuda & Koichi Mizuta. (2015) The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation: The experience of a single center. Pediatric Transplantation 19:3, pages 279-286.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.